Is somatostatin a peptide?

Two mature forms carry the somatostatin name

The National Library of Medicine names somatostatin-14 as a 14-amino-acid peptide. Its separate somatostatin-28 record names a 28-amino-acid peptide. These are two processed forms of the human hormone. The numbers describe the amino-acid units in each mature chain. They do not describe a dose, a blood level, or a strength comparison.

Somatostatin-28 includes the entire 14-unit sequence at its end and has 14 more units at the beginning. The MeSH record calls that beginning the N-terminal extension. In plain language, the longer form adds a section before the shorter form's shared ending. Both are peptides because their amino-acid units are connected in chains.

The name also describes a signaling role. Somatostatin is found in several parts of the body, including the nervous system and gut. The MeSH record describes effects on the release of other hormones. Those biological roles do not change the chemical class. A source can call it a hormone and a peptide without a conflict.

The 116-unit chain is the starting material

The reviewed human UniProt record P61278 has a full length of 116 amino-acid units. It marks positions 1 through 24 as a signal segment. A signal segment helps route a newly made chain inside a cell. Later processing leaves smaller named peptides. A 1982 study of human somatostatin messenger RNA also predicted a 116-unit starting chain with both mature forms at its end.

This is why a search result can give three different lengths for somatostatin. A 116-unit statement refers to the full precursor. A 28-unit statement refers to somatostatin-28. A 14-unit statement refers to somatostatin-14. Read the feature name beside a length before repeating that number as the size of the hormone.

UniProt also marks neuronostatin at positions 31 through 43 of the precursor. That is another named peptide feature. Its location is separate from the two somatostatin forms at the chain's end. Sharing a starting chain does not make neuronostatin a second name for somatostatin-14 or somatostatin-28.

The disulfide bond and position numbers

The human UniProt record marks a disulfide bond between precursor positions 105 and 116. A disulfide bond links two sulfur-containing cysteine units. It brings parts of the somatostatin chain together in a loop. The bond adds a connection within the molecule. It does not add amino-acid units to the chain.

In somatostatin-14, the feature begins at precursor position 103. Position 105 is therefore its third unit: 105 minus 103 plus 1 equals 3. Position 116 is its fourteenth. A chemistry source may describe a bond between units 3 and 14, while the sequence record uses 105 and 116. Both number the same marked connection from different starting points.

The same precursor positions are within somatostatin-28, which begins at 89. There they are units 17 and 28. This numbering change is useful when comparing two papers. It does not mean that the papers found different bonds. Confirm which molecule supplies the position numbers before comparing the notation.

Check the name against the sequence positions

The table gives the positions in the reviewed human precursor. Start with the exact feature name. Read its first and last positions, then include both ends in the count. This is a check on a reference record. It cannot tell which molecule is present in a physical sample.

For somatostatin-14, count positions 103 through 116. Subtract 103 from 116 and add one. The result is 14. For somatostatin-28, positions 89 through 116 give 116 minus 89 plus one, or 28. The second calculation includes the first 14 units of the longer form and the shared 14-unit ending.

A hypothetical note says, 'Somatostatin is 116 amino acids, so the 14-unit form must be a different gene.' The first number belongs to the precursor. The shorter feature sits at positions 103 through 116 of that same human record. The note does not need a second gene to explain those two lengths.

The record marks neuronostatin at 31 through 43, which counts to 13 units. Keep that name in its own row when reading a source. A peptide from the same precursor can have a different name and location. The table separates a shared origin from an identical molecule.

Octreotide is an analogue with its own record

An analogue is a different molecule designed to act in a related way. The U.S. Food and Drug Administration's 2024 Sandostatin LAR Depot label describes octreotide as a cyclic eight-unit peptide with actions that mimic natural somatostatin. Eight units distinguish it from the human 14- and 28-unit forms. The label names octreotide acetate as the product's active ingredient.

A label about octreotide therefore does not describe the sequence of natural somatostatin-14. Nor does a sequence record for somatostatin establish a medicine's approved use, formulation, or outcome. For a statement about an approved product, read the current label for that exact product. For the title's classification question, use the human sequence and molecule names.

The FDA label also describes warnings and the exact use of its named product. Those parts belong to the product record, not to every molecule that binds a somatostatin receptor. A shared receptor or the word analogue is a reason to check identity, not a reason to transfer evidence from one compound to another.

Use the exact form when reading a claim

First, write the complete name used by the source. Look for somatostatin-14, somatostatin-28, the 116-unit precursor, or a named analogue. Next, note whether the source is a sequence record, a chemistry description, a laboratory result, or a product label. Each type answers a different question.

The human sequence study supports the predicted starting chain and its ending forms. UniProt supplies reviewed positions for a length check. MeSH supplies plain names for the 14- and 28-unit peptides. The octreotide label identifies an approved product's active ingredient. None of these sources alone interprets a person's hormone test or proves a treatment result for another molecule.

For the simple classification question, both mature somatostatin forms are peptides. When a new claim gives one length or one effect, match it to the named form and the measurement in that source. The table above lets a reader check a length before carrying the claim into a different setting.